Answers are grounded in this paper and cite their sources.
We report for the first time a patient with malaria due to Plasmodium vivax who showed R2 resistance to chloroquine and R3 resistance to mefloquine in the Brazilian Amazon region based on WHO clinical criteria for diagnosis of malaria resistance. Failure was observed with unsupervised oral chloroquine, chloroquine under rigorous supervision and mefloquine in the same scheme. Finally, the patient was cured with oral artesunate.
No takes yet. Share an insight, caveat, or question.
Alecrim et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: